Aggregation Time Machine: A Platform for the Prediction and Optimization of Long-Term Antibody Stability Using...

Area of Science:

• Biopharmaceutical development
• Protein aggregation science
• Therapeutic antibody research

Background:

• Monoclonal antibodies represent a rapidly expanding therapeutic class.
• Antibody aggregation poses significant challenges, limiting shelf-life and potentially causing adverse immune reactions.
• Ensuring long-term antibody stability is critical for biologic drug development.

Purpose of the Study:

• To present a novel platform for rapid assessment of long-term antibody aggregation stability.
• To accelerate the optimization of antibody formulations for therapeutic use.
• To improve the understanding of antibody aggregation mechanisms.

Main Methods:

• Analysis of temperature-dependent aggregation data.
• Kinetic and thermodynamic analysis of antibody aggregation.
• Prediction of aggregate fractions over extended time periods (up to three years).

Main Results:

• Accurate prediction of aggregate fractions for therapeutic antibodies up to three years.
• Data obtained on a short time scale effectively predicts long-term stability.
• The platform significantly shortens the assessment period for antibody aggregation.

Conclusions:

• The developed platform enables rapid and accurate prediction of long-term antibody aggregation stability.
• This approach accelerates the optimization of antibody formulations in biologic drug development.
• The combined kinetic and thermodynamic strategy enhances understanding of aggregation mechanisms and aids therapeutic development.